ArticleDiscover oncology2026
Multi-omics analysis reveals the role of the XRCC gene family in diagnosis, prognosis, and immunity in pan-cancer.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Members of the XRCC family have been reported to be closely associated with the initiation and progression of certain human cancers. The purpose of this study is to comprehensively analyze the role of the XRCC family in pan-cancer. In this study, we primarily utilized data downloaded from The Cancer Genome Atlas (TCGA). We investigated the prognostic significance of the XRCC family and its association with tumor mutation burden (TMB), microsatellite instability (MSI), drug sensitivity, and immunotherapy in several human cancers. The findings indicated that the expression of the XRCC family was primarily upregulated in most tumors. The XRCC family was associated with the prognosis of cancer patients. Then, XRCC family genes showed a significant association with tumor immune microenvironment and tumor cell stemness. Finally, we also analyzed the potential role of the XRCC family in cancer therapy. This study conducts a comprehensive analysis of the role of the XRCC family in pan-cancer, which contributes to providing a potential direction for cancer diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.